Cell-associated HIV RNA: a dynamic biomarker of viral persistence

被引:105
作者
Pasternak, Alexander O. [1 ]
Lukashov, Vladimir V. [1 ]
Berkhout, Ben [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands
来源
RETROVIROLOGY | 2013年 / 10卷
关键词
Cell-associated HIV RNA; Virological biomarker; HIV-1; persistence; reservoir; Antiretroviral therapy; HIV cure; IMMUNODEFICIENCY-VIRUS TYPE-1; REAL-TIME PCR; ACTIVE ANTIRETROVIRAL THERAPY; BLOOD MONONUCLEAR-CELLS; LOW-LEVEL VIREMIA; CD4(+) T-CELLS; COURSE RALTEGRAVIR INTENSIFICATION; HIGHLY SENSITIVE METHODS; IN-SITU HYBRIDIZATION; MESSENGER-RNA;
D O I
10.1186/1742-4690-10-41
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In most HIV-infected individuals adherent to modern antiretroviral therapy (ART), plasma viremia stays undetectable by clinical assays and therefore, additional virological markers for monitoring and predicting therapy responses and for measuring the degree of HIV persistence in patients on ART should be identified. For the above purposes, quantitation of cell-associated HIV biomarkers could provide a useful alternative to measurements of viral RNA in plasma. This review concentrates on cell-associated (CA) HIV RNA with the emphasis on its use as a virological biomarker. We discuss the significance of CA HIV RNA as a prognostic marker of disease progression in untreated patients and as an indicator of residual virus replication and the size of the dynamic viral reservoir in ART-treated patients. Potential value
引用
收藏
页数:15
相关论文
共 167 条
[31]   ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED TISSUES BY AMPLIFICATION AND INSITU HYBRIDIZATION REVEALS LATENT AND PERMISSIVE INFECTIONS AT SINGLE-CELL RESOLUTION [J].
EMBRETSON, J ;
ZUPANCIC, M ;
BENEKE, J ;
TILL, M ;
WOLINSKY, S ;
RIBAS, JL ;
BURKE, A ;
HAASE, AT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (01) :357-361
[32]   Absence of HIV-1 Evolution in the Gut-Associated Lymphoid Tissue from Patients on Combination Antiviral Therapy Initiated during Primary Infection [J].
Evering, Teresa H. ;
Mehandru, Saurabh ;
Racz, Paul ;
Tenner-Racz, Klara ;
Poles, Michael A. ;
Figueroa, Amir ;
Mohri, Hiroshi ;
Markowitz, Martin .
PLOS PATHOGENS, 2012, 8 (02)
[33]   Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 Vif gene expression [J].
Exline, C. M. ;
Feng, Z. ;
Stoltzfus, C. M. .
JOURNAL OF VIROLOGY, 2008, 82 (08) :3921-3931
[34]   Viral dynamics in HIV-1 infection [J].
Finzi, D ;
Siliciano, RF .
CELL, 1998, 93 (05) :665-671
[35]   Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapy [J].
Fischer, M ;
Günthard, HF ;
Opravil, M ;
Joos, B ;
Huber, W ;
Bisset, LR ;
Ott, P ;
Böni, J ;
Weber, R ;
Cone, RW .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (12) :1135-1140
[36]   Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef [J].
Fischer, M ;
Joos, B ;
Hirschel, B ;
Bleiber, G ;
Weber, R ;
Günthard, HF .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (11) :1979-1988
[37]   Attenuated and nonproductive viral transcription in the lymphatic tissue of HIV-1-infected patients receiving potent antiretroviral therapy [J].
Fischer, M ;
Joos, B ;
Wong, JK ;
Ott, P ;
Opravil, M ;
Hirschel, B ;
Weber, R ;
Günthard, HF .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (02) :273-285
[38]   Highly sensitive methods for quantitation of human immunodeficiency virus type 1 RNA from plasma, cells, and tissues [J].
Fischer, M ;
Huber, W ;
Kallivroussis, A ;
Ott, P ;
Opravil, M ;
Lüthy, R ;
Weber, R ;
Cone, RW .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) :1260-1264
[39]  
Fischer M, 2003, ANTIVIR THER, V8, P97
[40]  
Fischer M, 2002, ANTIVIR THER, V7, P91